Vertex Pharmaceuticals
VRTX
#180
Rank
C$157.23 B
Marketcap
C$613.25
Share price
1.75%
Change (1 day)
-7.79%
Change (1 year)

Market capitalization of Vertex Pharmaceuticals (VRTX)

Market cap: C$157.23 Billion

As of December 2025 Vertex Pharmaceuticals has a market cap of C$157.23 Billion. This makes Vertex Pharmaceuticals the world's 180th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Vertex Pharmaceuticals from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025C$157.23 B4.09%
2024C$151.05 B8.62%
2023C$139.06 B38.25%
2022C$100.58 B41.22%
2021C$71.22 B-9.11%
2020C$78.36 B5.81%
2019C$74.06 B28.58%
2018C$57.60 B20.88%
2017C$47.64 B94.05%
2016C$24.55 B-42.88%
2015C$42.99 B28.99%
2014C$33.33 B80.26%
2013C$18.49 B104.24%
2012C$9.05 B28.5%
2011C$7.04 B-1.14%
2010C$7.12 B-20.95%
2009C$9.01 B72.44%
2008C$5.22 B69.78%
2007C$3.07 B-43.96%
2006C$5.49 B57.71%
2005C$3.48 B239.8%
2004C$1.02 B-2.12%
2003C$1.04 B-45.2%
2002C$1.91 B-34.99%
2001C$2.94 B-53.96%
2000C$6.38 B392.51%
1999C$1.29 B11.78%
1998C$1.15 B-2.44%
1997C$1.18 B2.22%
1996C$1.16 B

End of Day market cap according to different sources

On Dec 10th, 2025 the market cap of Vertex Pharmaceuticals was reported to be:

C$155.59 Billion
by Nasdaq info icon info icon
C$157.23 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
C$207.65 B 32.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$548.89 B 249.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$336.29 B 113.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$143.78 B-8.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$686.31 B 336.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
C$0.57 B-99.64%๐Ÿ‡บ๐Ÿ‡ธ USA